Corcept Therapeutics Inc (CORT)
54.63
-2.05
(-3.62%)
USD |
NASDAQ |
Mar 28, 16:00
58.79
+4.16
(+7.61%)
After-Hours: 20:00
Corcept Therapeutics Total Liabilities (Quarterly): 160.96M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 123.78M |
| Nektar Therapeutics | 243.11M |
| Supernus Pharmaceuticals Inc | 332.34M |
| Bristol-Myers Squibb Co | 76.22B |
| ACADIA Pharmaceuticals Inc | 454.96M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 840.55M |
| Shareholders Equity (Quarterly) | 679.59M |
| Current Ratio | 3.350 |